Clinical trial

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis

NCT00004744

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1993-02-01

PhasePHASE3

Study timeline

Study start (unknown)1993-02-01Date precision: month

Registry last updated2008-09-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

immune globulinDRUG

Sponsors & collaborators

National Institute of Neurological Disorders and Stroke (NINDS)lead sponsor

Mayo Cliniccollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00004744 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.